1328-Synergistic Radiopharmaceutical for Neuroblastoma

Paper Talk · Jul 24, 2026 · 22m

This research article demonstrates that combining VLA-4-targeted radiopharmaceutical therapy (RPT) with CAR T cell therapy significantly improves treatment outcomes for neuroblastoma, a difficult-to-treat pediatric cancer. The authors found that this dual approach effectively eliminates tumors in both radio-sensitive and radio-resistant mouse models through distinct biological mechanisms. In sensitive tumors, the radiation provides a direct killing effect while triggering a TNF-α inflammatory response that activates nearby T cells. Conversely, in resistant tumors, the therapy remodels the…